American Journal of Clinical Dermatology

Article	Citations
The Current State of Systemic Therapy of Metastatic Uveal Melanoma	150
Alcohol and Smoking Cessation as Potential Modulators for Smoking-Associated Psoriasis Risk in Postmenopausal Women: The Women’s Health Initiative	138
Prognostic Biomarkers in Evolving Melanoma Immunotherapy	133
Role of Inflammation and Cytokine Dysregulation in Depression in Patients with Inflammatory Skin Conditions	124
Economic Burden of Chronic Hand Eczema: A Review	94
Pyoderma Gangrenosum: An Updated Literature Review on Established and Emerging Pharmacological Treatments	90
New Onset and Exacerbations of Psoriasis Following COVID-19 Vaccines: A Systematic Review	89
Deciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments	85
Predicting the Time to Relapse Following Withdrawal from Different Biologics in Patients with Psoriasis who Responded to Therapy: A 12-Year Multicenter Cohort Study	81
Stepping Down Treatment in Chronic Spontaneous Urticaria: What We Know and What We Don’t Know	73
Efficacy and Safety of Nail Psoriasis Targeted Therapies: A Systematic Review	68
Obesity in Hidradenitis Suppurativa: Are GLP-1 Receptor Agonists the New Frontier?	67
Pathophysiology of Generalized Pustular Psoriasis	66
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data	61
Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology	58
Agreement Between Nail Psoriasis Severity Index Scores by a Convolutional Neural Network and Dermatologists: A Retrospective Study at an Academic New York City Institution	52
Behçet Disease: An Update for Dermatologists	52
Primary Localized Cutaneous Amyloidosis of Keratinocyte Origin: An Update with Emphasis on Atypical Clinical Variants	49
A Practical Approach to the Diagnosis and Management of Classic Lichen Planopilaris	49
Assessment of Efficacy and Safety Outcomes Beyond Week 16 in Clinical Trials of Systemic Agents Used for the Treatment of Moderate to Severe Atopic Dermatitis in Combination with Topical Corticosteroi	47
Viral Venereal Diseases of the Skin	47
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”	46
Lessons Learned from Orthopedics: A Call to Action for More Rigorous Platelet-Rich Plasma Hair Loss Clinical Trials	45
Correction to: Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	44
Safety of Baricitinib in Adults with Severe Alopecia Areata from Two Phase III Trials Over a Median of 2.3 Years and Up to 4 Years of Treatment	43

Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature	43
Inpatient Teledermatology Improves Diagnostic Accuracy and Management of Leg Ulcers in Hospitalized Patients	42
Skin Cancer in People of Color: A Systematic Review	42
Drug Survival of Oral Retinoids in Hidradenitis Suppurativa: A Real-Life Cohort Study	42
Correction to: Long-term Effectiveness and Safety of Upadacitinib for Atopic Dermatitis in a Real-world Setting: An Interim Analysis Through 48 Weeks of Observation	42
A Practice Approach to Acne Fulminans in Adolescents	39
Truncal Acne and Scarring: A Comprehensive Review of Current Medical and Cosmetic Approaches to Treatment and Patient Management	39
Real-World Evidence on Dose Spacing of IL-23 Inhibitors in the Treatment of Psoriasis	38
Atopic Dermatitis: Fertility, Pregnancy, and Treatment Perspectives	38
Biomarkers in Atopic Dermatitis: A Review of the Role of IL-13 and the Impact of Tralokinumab Treatment	36
Correction to: AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment Hist	36
Real-World Evidence of Tralokinumab Effectiveness and Safety: A Systematic Review and Meta-analysis	36
Management and Long-Term Outcomes of Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS) in Children: A Scoping Review	35
Long-Term Safety and Tolerability of Beremagene Geperpavec-svdt (B-VEC) in an Open-Label Extension Study of Patients with Dystrophic Epidermolysis Bullosa	34
Scratching the Surface: A Comprehensive Guide to Understanding and Managing Vulvovaginal Itching	34
Merkel Cell Carcinoma: Integrating Epidemiology, Immunology, and Therapeutic Updates	34
The Use of Biologic Agents for the Treatment of Cutaneous Immune-Related Adverse Events from Immune Checkpoint Inhibitors: A Review of Reported Cases	33
Patient and Public Involvement in Dermatology Research: A Review	33
Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	32
Appraisal of Proactive Topical Therapy in Atopic Dermatitis: Pros and Cons	30
Oral Lichen Planus: An Update on Diagnosis and Management	30
Granuloma Annulare: An Updated Review of Epidemiology, Pathogenesis, and Treatment Options	30
A Review of the Etiologies and Key Clinical Features of Secondary Hyperhidrosis	30
Frontal Fibrosing Alopecia: An Update	29
Differential Diagnosis, Prevention, and Treatment of mpox (Monkeypox): A Review for Dermatologists	29
Commentary on “Patient-Reported Outcome Measures and Their Clinical Applications in Dermatology”	29
Individualized Neoantigen-Directed Melanoma Therapy	29
Tree-Based Machine Learning to Identify Predictors of Psoriasis Incidence at the Neighborhood Level: A Populational Study from Quebec, Canada	28
Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study	28
Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	27
AtopyReg®, the Prospective Italian Patient Registry for Moderate-to-Severe Atopic Dermatitis in Adults: Baseline Demographics, Disease Characteristics, Comorbidities, and Treatment History	27
Targeting Inflammation in Acne: Current Treatments and Future Prospects	27
JAK Inhibitors and Inflammatory Nail Disorders: A Systematic Review of Clinical Outcomes and Therapeutic Potential	27
Intravenous Immunoglobulin Therapy for Pyoderma Gangrenosum: A Multicenter Retrospective Analysis in 81 Patients	26
Efficacy and Safety of Baricitinib in Patients with Severe Alopecia Areata over 52 Weeks of Continuous Therapy in Two Phase III Trials (BRAVE-AA1 and BRAVE-AA2)	26
Autoimmune and Cutaneous Inflammatory Comorbidities in Adult-Onset Morphea in the All of Us Research Program	25
Management of Acne in Pregnancy	25
Approach to the Atypical Wound	23
Cutaneous Small Vessel Vasculitis: A Practical Guide to Diagnosis and Management	22
Comment on: “Eyebrow and Eyelash Alopecia: A Clinical Review”	22
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study	21
Acknowledgement to Referees	21
Beyond the Herald Patch: Exploring the Complex Landscape of Pityriasis Rosea	21
Identifying and Treating Ocular Manifestations in Psoriasis	21
Systemic Versus Topical Corticosteroids in the Treatment of DRESS: A Retrospective Cohort Study Followed by a Meta-Analysis	20
Real-World Use of Ruxolitinib Cream: Safety Analysis at 1 Year	20
Burden to Partners of People with Psoriasis: Results from the FamilyPso International Study	20
Impact of Generalized Pustular Psoriasis from the Perspective of People Living with the Condition: Results of an Online Survey	20
Investigational Treatments for Epidermolysis Bullosa	20
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for Clinicians	20

Disease Burden and Treatment Patterns Among US Patients with Hidradenitis Suppurativa: A Retrospective Cohort Study	19
Publisher Correction to: Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials	19
Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion	19
Comprehensive and Updated Algorithm of Hidradenitis Suppurativa Management from the Experts	19
Review of Perineural Invasion in Keratinocyte Carcinomas	19
Interpreting the Relationship Among Itch, Sleep, and Work Productivity in Patients with Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of JADE MONO-2	19
Review of Laser Treatments for Post-Inflammatory Hyperpigmentation in Skin of Color	19
Treatment Strategies for Chronic Pruritus and Eczema/Dermatitis in Older Adults Under the Category of Chronic Eczematous Eruptions of Aging (CEEA)	19
The 25th World Congress of Dermatology, Singapore, 3–8 July, 2023: Research Highlights	18
Autoimmune, Autoinflammatory Disease and Cutaneous Malignancy Associations with Hidradenitis Suppurativa: A Cross-Sectional Study	18
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study	18
An Update on New and Existing Treatments for the Management of Melasma	17
Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	17
Evaluation of the Tolerability of Hedgehog Pathway Inhibitors in the Treatment of Advanced Basal Cell Carcinoma: A Narrative Review of Treatment Strategies	17
Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies	17
Ceramides in Skin Health and Disease: An Update	17
Treatment of Hyperhidrosis: An Update	17
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents	17
Correction to: Authors’ Reply to Chen and Chen: Comment on: “Isotretinoin Exposure and Risk of Inflammatory Bowel Disease: A Systematic Review with Meta-Analysis and Trial Sequential Analysis”	17
Safety of Hydroxychloroquine: What a Dermatologist Should Know	17
Patient Care Outcomes in Hospitalized Patients with Acute Generalized Exanthematous Pustulosis: A Cross-Sectional Database Study	16
Abscopal Effects and Immunomodulation in Skin Cancer Therapy	16
Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies	16
Update in Diagnosis and Management of Primary Cutaneous B-Cell Lymphomas	16
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study	15
The Skin and Gut Microbiome in Hidradenitis Suppurativa: Current Understanding and Future Considerations for Research and Treatment	15
Management of Coexisting Bullous Pemphigoid and Psoriasis: A Review	15
Review of an Anti-CD20 Monoclonal Antibody for the Treatment of Autoimmune Diseases of the Skin	15
Safety of Lebrikizumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: An Integrated Analysis of Eight Clinical Trials	15
Phase II, Double-Blind, Vehicle-Controlled Study to Determine the Cantharidin Dose Regimen, Efficacy, Safety, and Tolerability of VP-102 in Subjects with External Genital Warts	15
Real-World Experience of Bimekizumab for Plaque Psoriasis in Adult Patients with Prior Exposure to Interleukin-23 Inhibitors: A Multicenter Retrospective Study	15
Psychosocial Effects of Vitiligo: A Systematic Literature Review	15
Impact of Facial Atrophic Acne Scars on Quality of Life: A Multi-country Population-Based Survey	15
Automated Facial Acne Lesion Detecting and Counting Algorithm for Acne Severity Evaluation and Its Utility in Assisting Dermatologists	14
Atopic Dermatitis Across Shades of Skin	14
Lichen Planus: What is New in Diagnosis and Treatment?	14
Authors’ reply to Borg and Thoning: “Comment on: Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment: A Retrospective Multi-Country, Multicentric Cohort Study”	13
Human Inborn Errors of Immunity in Pyoderma Gangrenosum: A Systematic Review	13
Blue Nail Discoloration: Literature Review and Diagnostic Algorithms	13
New Practical Aspects of Sweet Syndrome	13
Oral Roflumilast in Patients with Psoriasis: A Real-World Cohort Study	13
KECORT Study: An International e-Delphi Study on the Treatment of KEloids Using Intralesional CORTicosteroids in Clinical Practice	13
Diagnosis of Generalized Pustular Psoriasis	12
Meat Allergy: A Ticking Time Bomb	12
Suggestions for a New Clinical Classification Approach to Panniculitis Based on a Mayo Clinic Experience of 207 Cases	12
Cholestatic Itch: Our Current Understanding of Pathophysiology and Treatments	12
Dapsone Use in Dermatology	12
Ruxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis	12
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview	12
Correction to: The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma	12
Efinaconazole in Onychomycosis	11
What’s New in Therapy for Male Androgenetic Alopecia?	11
Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial	11
Recommendations for Vaccination in Children with Atopic Dermatitis Treated with Dupilumab: A Consensus Meeting, 2020	11
Correction to: Adherence to Hidradenitis Suppurativa Treatment	11
Ultrasound Surveillance in Melanoma Management: Bridging Diagnostic Promise with Real-World Adherence: A Systematic Review and Meta-Analysis	11
Vulvar Melanoma: Molecular Characteristics, Diagnosis, Surgical Management, and Medical Treatment	10
Eyebrow and Eyelash Alopecia: A Clinical Review	10
Chronic Prurigo Including Prurigo Nodularis: New Insights and Treatments	10
Cellulitis in Pediatric Patients: Recognition and Management in the Era of Evolving Resistance	10
Correction to: Impact of Oral Abrocitinib Monotherapy on Patient-Reported Symptoms and Quality of Life in Adolescents and Adults with Moderate-to-Severe Atopic Dermatitis: A Pooled Analysis of Patient	10
Alopecia Areata: Current Treatments and New Directions	10
Features and Long-Term Outcomes of Stage IV Melanoma Patients Achieving Complete Response Under Anti-PD-1-Based Immunotherapy	9
Correction to: Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	9
Early and Sustained Improvements in Symptoms and Quality of Life with Upadacitinib in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: 52-Week Results from Two Phase III Randomized Cl	9
Correction to: Integrated Safety Analysis of Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis From the Phase II and Phase III Clinical Trial Program	9
Field Cancerization Therapies for the Management of Actinic Keratosis: An Updated Review	9
A Guide to the Management of Hidradenitis Suppurativa in Pregnancy and Lactation	9
Beyond the Hot Comb: Updates in Epidemiology, Pathogenesis, and Treatment of Central Centrifugal Cicatricial Alopecia from 2011 to 2021	9
Deucravacitinib for the Treatment of Psoriatic Disease	9
Adherence to Hidradenitis Suppurativa Treatment	9
Skin Toxicities with Cyclin-Dependent Kinase 4/6 Inhibitors in Breast Cancer: Signals from Disproportionality Analysis of the FDA Adverse Event Reporting System	9
Comment on: “Methotrexate Cutaneous Ulceration: A Systematic Review of Cases”	9
The Role of Diet Modification in Atopic Dermatitis: Navigating the Complexity	9
Secukinumab in Pediatric Patients with Plaque Psoriasis: Pooled Safety Analysis from Two Phase 3 Randomized Clinical Trials	8
Lebrikizumab for the Treatment of Moderate-to-Severe Atopic Dermatitis	8
Publisher Correction to: Multiple Keratoacanthomas Associated with Genetic Syndromes: Narrative Review and Proposal of a Diagnostic Algorithm	8
Psychological Therapies and Mind–Body Techniques in the Management of Dermatologic Diseases: A Systematic Review	8
Relationship of Histopathologic Parameters and Gene Expression Profiling in Malignant Melanoma	8
Pruritus in Pregnancy	8

Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice	7
Association of Cardiovascular Disease and Chronic Spontaneous Urticaria: A Case–Control Study	7
Development of Cutaneous T-Cell Lymphoma Following Biologic Treatment: A Systematic Review	7
Efficacy and Safety of Abrocitinib in Patients with Severe and/or Difficult-to-Treat Atopic Dermatitis: A Post Hoc Analysis of the Randomized Phase 3 JADE COMPARE Trial	7
Stasis Dermatitis: An Overview of Its Clinical Presentation, Pathogenesis, and Management	7
Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial	7
Maximal Usage Trial of Tapinarof Cream 1% Once Daily in Pediatric Patients Down to 2 Years of Age with Extensive Atopic Dermatitis	7
Hidradenitis Suppurativa: New Targets and Emerging Treatments	7
American Academy of Dermatology Annual Meeting: San Diego, CA, USA, 8–12 March 2024	6
Expert Perspectives on Key Parameters that Impact Interpretation of Randomized Clinical Trials in Moderate-to-Severe Atopic Dermatitis	6
Characterization of Clinicopathological Features and Autoantibody Profiles in Patients with Cutaneous Lupus Erythematous: A Single-Center Retrospective Study	6
Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review	6
Efficacy and Safety of Brodalumab, an Anti-interleukin-17 Receptor A Monoclonal Antibody, for Palmoplantar Pustulosis: 16-Week Results of a Randomized Clinical Trial	6
Lactobacillus rhamnosus Used in the Perinatal Period for the Prevention of Atopic Dermatitis in Infants: A Systematic Review and Meta-Analysis of Randomized Trials	6
Global Incidence, Mortality, Risk Factors and Trends of Melanoma: A Systematic Analysis of Registries	6
Determinants and Effectiveness of BNT162b2 mRNA Vaccination Among Patients with Atopic Dermatitis: A Population-Based Study	6
Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program	6
Clinical Efficacy and Safety of Interleukin-17 Inhibitors in Treating Patients with Erythrodermic Psoriasis: A Retrospective Cohort, Three-Center Study	6
Sequencing of Targeted Therapy in Psoriasis: Does it Matter?	6
Acknowledgment to Referees	6
Rare Autoinflammatory Neutrophilic Dermatoses in Pregnancy: Literature Review	6